里斯迪普拉姆:一种小分子mRNA拼接修饰剂已被批准用于治疗SMA疾病
Lutz Müller1, Björn Jacobsen1, Alexander Nürnberg1
1F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Toxicologic pathology
|November 18, 2025
概括
里斯迪普拉姆是一种mRNA拼接修饰剂,已经帮助成千上万的脊髓肌肉缩. 它的非临床开发面临毒理障碍,被新的策略所克服,导致临床成功.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 遗传学 是一个遗传学.
背景情况:
- 里斯迪普拉姆是唯一批准的小分子mRNA拼接修饰剂.
- 它已在治疗脊髓肌肉缩 (SMA) 方面使用了五年多.
- 成千上万的SMA患者从risdiplam治疗中受益.
研究的目的:
- 审查risdiplam的非临床发展.
- 专注于动物模型中的毒理学表征和组织病理学发现.
- 突出用于克服发展挑战的战略.
主要方法:
- 对risdiplam进行的非临床研究的审查.
- 动物研究中的毒理学数据的分析.
- 在接受治疗的动物中检查基因病理特征.
主要成果:
- 非临床开发遇到了重大的毒理挑战.
- 为了应对这些挑战,开发了创新策略.
- 这些策略对于risdiplam的最终临床成功至关重要.
结论:
- 里斯迪普拉姆的非临床开发证明了复杂的毒理学问题的成功导航.
- 动物研究中的组织病理学发现为安全性评估提供了信息.
- 克服非临床毒性是risdiplam在SMA治疗应用的关键.
关键词:
在SMN2中使用SMN2.男性的生殖细胞是男性的生殖细胞.视网膜 视网膜 视网膜 是一个里斯迪普拉姆的风险二次拼接的目标是二次拼接的目标.脊柱肌肉缩 脊柱肌肉缩 脊柱肌肉缩拼接修饰器 拼接修饰器更多相关视频
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
8.1K
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
7.3K
相关概念视频
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Alternative RNA Splicing
24.6K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.6K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Riboswitches
9.5K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
9.5K
